ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

accord healthcare s.l.u. - cinacalcet hydroklorid - hyperparathyroidism - kalsiumhomeostase - sekundær hyperparathyroidismadultstreatment av sekundær hyperparathyroidism (hpt) hos voksne pasienter med end-stage renal disease (esrd) på vedlikehold dialyse terapi. paediatric populationtreatment av sekundær hyperparathyroidism (hpt) hos barn i alderen 3 år og eldre med end-stage renal disease (esrd) på vedlikehold dialyse behandling som sekundær hpt ikke er tilstrekkelig kontrollert med standarden på omsorg terapi (se kapittel 4. cinacalcet accordpharma kan brukes som en del av en terapeutisk regime inkluderer fosfat permer og/eller vitamin d sterols som er aktuelt (se punkt 5.. parathyroid karsinom og primary hyperparathyroidism i adultsreduction av hyperkalsemi hos voksne pasienter med:parathyroid carcinoma. primære hpt for hvem parathyroidectomy ville være angitt på grunnlag av serum kalsium nivåer (som definert av relevante retningslinjer for behandling), men i hvem parathyroidectomy er ikke klinisk relevant eller er kontraindisert.

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

orifarm generics a/s - alitretinoin - kapsel, myk - 10 mg

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

orifarm generics a/s - alitretinoin - kapsel, myk - 30 mg

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

glenmark arzneimittel gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 40 mg

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

glenmark arzneimittel gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 5 mg

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

glenmark arzneimittel gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 10 mg

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

glenmark arzneimittel gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 20 mg

ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

mylan ireland limited - lenalidomid - multippelt myelom - immunsuppressive - multiple myelomalenalidomide mylan as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide mylan as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for transplant. lenalidomide mylan in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide mylan in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1-3a).

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

mylan ab - amlodipinbesilat / valsartan / hydroklortiazid - tablett, filmdrasjert - 10 mg / 160 mg / 12.5 mg

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

mylan ab - amlodipinbesilat / valsartan / hydroklortiazid - tablett, filmdrasjert - 5 mg / 160 mg / 12.5 mg